Download PDF
Thromb Haemost 1997; 78(03): 1161-1162
DOI: 10.1055/s-0038-1657706
Letter to the Editor
Schattauer GmbH Stuttgart

Prevalence of Factor V Leiden in Accelerated Forms of Coronary Artery Disease

James C Fang
The Cardiovascular Division (JCF, PMR), Department of Medicine, Brigham and Women’s Hospital, Boston, MA and the Division of Laboratory Medicine (JPM), Washington University School of Medicine, St. Louis, MO, USA
,
Joseph P Miletich
The Cardiovascular Division (JCF, PMR), Department of Medicine, Brigham and Women’s Hospital, Boston, MA and the Division of Laboratory Medicine (JPM), Washington University School of Medicine, St. Louis, MO, USA
,
Paul M Ridker
The Cardiovascular Division (JCF, PMR), Department of Medicine, Brigham and Women’s Hospital, Boston, MA and the Division of Laboratory Medicine (JPM), Washington University School of Medicine, St. Louis, MO, USA
› Author Affiliations
Further Information

Publication History

Received 18 1997

Accepted after revision 05 May 1997

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Dahlbäck B. New Molecular Insights into the Genetics of Thrombophilia: Resistance to Activated Protein C Caused by Arg506 to Gin Mutation in Fac tor V as a Pathogenic Risk Factor for Venous Thrombosis. Thromb Haemost 1995; 74 (01) 139-148
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Svensson PJ, Dahlbäck B. Resistance of Activated Protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
    CrossrefPubMedGoogle Scholar
  • 3 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men. N Engl J Med 1995; 332: 912-917
    CrossrefPubMedGoogle Scholar
  • 4 Samani NJ, Lodwick D, Martin D, Kimber P. Resistance to Activated Protein C and Risk of Premature Myocardial Infarction. Lancet 1994; 344: 1709-1710
    PubMedGoogle Scholar
  • 5 Holm J, Zӧller B, Svensson PJ, Bemtorp E, Erhardt L, Dahlbäck B. Myocar dial Infarction Associated with Homozygous Resistance to Activated Protein C. Lancet 1994; 344: 952-953
    PubMedGoogle Scholar
  • 6 Marz W, Seydewitz H, Winkelmann B, Chen M, Nauck M, Witt I. Mutation in Coagulation Factor V Associated with Resistance to Activated Protein C in Patients with Coronary Artery Disease. Lancet 1995; 345: 526-527
    CrossrefPubMedGoogle Scholar
  • 7 Labarrere CA, Pitts D, Nelson DR, Faulk WP. Vascular Tissue Plasminogen Activator and the Development of Coronary Artery Disease in Heart-Trans- plant Recipients. N Engl J Med 1995; 333: 1111-1116
    CrossrefPubMedGoogle Scholar
  • 8 Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic Distribution of Factor V Leiden Among 4047 Men and Women: Implications for Screening and Prevention of Venous Thromboembolism. JAMA 1997; 277: 1305-1307
    CrossrefPubMedGoogle Scholar